25 results
424B5
SERA
Sera Prognostics, Inc.
11 Feb 25
Prospectus supplement for primary offering
5:03pm
an infant preterm. The PreTRM test classified 23.5% of participants as higher risk within the preterm birth prevention arm. In addition
424B5
SERA
Sera Prognostics, Inc.
10 Feb 25
Prospectus supplement for primary offering
4:27pm
of delivering an infant preterm. The PreTRM test classified 23.5% of participants as higher risk within the preterm birth prevention arm. In addition
8-K
SERA
Sera Prognostics, Inc.
31 Jan 25
Results of Operations and Financial Condition
1:31pm
. The PreTRM Test classified 23.5% of participants as higher risk within the preterm birth prevention arm. In addition to the traditional standard of care
ARS
pvt zyyoqi
23 Apr 24
Annual report to shareholders
4:11pm
ARS
hdx99i cdd0z5y8
25 Apr 23
Annual report to shareholders
4:15pm
10-K
hmg6377o7 fh13
29 Mar 22
Annual report
4:08pm
10-Q
qst jo968a2
30 Aug 21
Quarterly report
4:29pm
424B4
p7qdo7kl8w 0kuyx88vq
16 Jul 21
Prospectus supplement with pricing info
4:14pm
S-1/A
2nhwrrd5fiuf
8 Jul 21
IPO registration (amended)
6:16am